DNAJC12 downregulation induces neuroblastoma progression via increased histone H4K5 lactylation
Journal of Molecular Cell Biology · 2025
DOI: 10.1093/jmcb/mjae056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2025. Verfasst von Yaqi Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, Ch…. Hauptthemen laut MEDLINE: Histones, Neuroblastoma, Down-Regulation, HSP40 Heat-Shock Proteins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Natural Science Foundation of Shanghai, Science and Technology Development Fund.
Abstract (Originalsprache)
Neuroblastoma (NB) is the most common extracranial solid tumor in children. Despite treatment advances, the survival rates of high-risk NB patients remain low. This highlights the urgent need for a deeper understanding of the molecular mechanisms driving NB progression to support the development of new therapeutic strategies. In this study, we demonstrated that the reduced levels of DNAJC12, a protein involved in metabolic regulation, are associated with poor prognosis in NB patients. Our data indicate that low DNAJC12 expression activates glycolysis in NB cells, leading to increased lactic acid production and histone H4 lysine 5 lactylation (H4K5la). Elevated H4K5la upregulates the transcription of COL1A1, a gene implicated in cell metastasis. Immunohistochemistry staining of NB patient samples confirmed that high H4K5la levels correlate with poor clinical outcomes. Furthermore, we showed that inhibiting glycolysis, reducing H4K5la, or targeting COL1A1 can mitigate the invasive behavior of NB cells. These findings reveal a critical link between metabolic reprogramming and epigenetic modifications in the context of NB progression, suggesting that H4K5la could serve as a novel diagnostic and prognostic marker, and shed light on identifying new therapeutic targets within metabolic pathways for the treatment of this aggressive pediatric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
- Pediatric Department, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310000, China.
- Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
- Department of Pathology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
- Department of Infectious Diseases, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
ORCID-Profile: Nan Shen
Förderung
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Shanghai
- Science and Technology Development Fund
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Yang, Y., Wen, J., Lou, S., Han, Y., Pan, Y., Zhong, Y., He, Q., Zhang, Y., Mo, X., Ma, J., & Shen, N. (2025). DNAJC12 downregulation induces neuroblastoma progression via increased histone H4K5 lactylation. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjae056
Vancouver
Yang Y, Wen J, Lou S, Han Y, Pan Y, Zhong Y, et al. DNAJC12 downregulation induces neuroblastoma progression via increased histone H4K5 lactylation. Journal of Molecular Cell Biology. 2025. doi:10.1093/jmcb/mjae056
BibTeX
@article{Yang2025,
author = {Yang, Yaqi and Wen, Jiejun and Lou, Susu and Han, Yali and Pan, Yi and Zhong, Ying and He, Qiao and Zhang, Yinfeng and Mo, Xi and Ma, Jing and Shen, Nan},
title = {DNAJC12 downregulation induces neuroblastoma progression via increased histone H4K5 lactylation},
journal = {Journal of Molecular Cell Biology},
year = {2025},
doi = {10.1093/jmcb/mjae056}
}
EUVIMED